Update on laryngopharyngeal reflux disease

咽喉反流 医学 疾病 内科学 回流
作者
Miguel Algara,Walter W. Chan
出处
期刊:Current Opinion in Gastroenterology [Lippincott Williams & Wilkins]
卷期号:41 (4): 251-259
标识
DOI:10.1097/mog.0000000000001108
摘要

Purpose of review Chronic laryngopharyngeal symptoms (LPS) are increasingly prevalent presentations to gastroenterologists’ offices, and clinicians often make a presumptive diagnosis of laryngopharyngeal reflux disease (LPRD) based on LPS symptoms or laryngoscopic findings alone. Such presumptive diagnoses of LPRD often are incorrect, and establishing the correct diagnosis poses significant challenges for clinicians. This review addresses the timely need for advances in evaluating and managing LPS/LPRD, given their diagnostic complexity and the healthcare burden of ineffective empiric treatments. Recent findings Recent evidence emphasizes the diverse etiologies of LPS including LPRD, oropharyngeal or other airway pathologies, allergic conditions, and cognitive-affective processes or altered brain-larynx interaction. The diagnostic approach should be individualized and multimodal, including upfront reflux testing over empiric acid suppression trials for possible LPRD, given the poor correlation between LPS and objective evidence of reflux. Predictive models and risk stratification tools such as the COuGH RefluX score show promise to help guide testing and therapeutic strategies. Reflux testing modalities include wireless pH monitoring and impedance-based testing (traditional impedance-pH or combined hypopharyngeal-esophageal reflux monitoring). Biochemical testing for salivary pepsin may also offer adjunctive value. Management should include antireflux strategies for those with objectively-proven LPRD, alongside treatments targeting nonreflux mechanisms of LPS, such as voice therapy, neuromodulation, and behavioral therapy. Summary An individualized, multidisciplinary approach is essential in managing LPS/LPRD. Objective reflux testing improves diagnostic accuracy, avoids unnecessary therapies, and enables tailored treatment. Future research should further refine diagnostic thresholds, validate risk stratification tools, and explore novel therapeutic targets to optimize outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
77877发布了新的文献求助10
刚刚
wanci的应助被青柠空采纳,获得10
刚刚
和谐的白亦完成签到 ,获得积分10
刚刚
1秒前
渝年完成签到 ,获得积分10
1秒前
贺梦凡发布了新的文献求助10
1秒前
esbd完成签到,获得积分10
1秒前
Tink完成签到,获得积分0
2秒前
Okkk完成签到,获得积分20
2秒前
jiejie59867完成签到,获得积分10
2秒前
汉堡包的应助被Romani采纳,获得10
3秒前
小犁牛完成签到 ,获得积分10
3秒前
4秒前
yangyangyang发布了新的文献求助10
4秒前
Non的应助被英勇的凤灵采纳,获得10
5秒前
在水一方的应助被YN采纳,获得10
5秒前
tuekiesman发布了新的文献求助10
6秒前
Ava的应助被海的呼唤采纳,获得10
6秒前
6秒前
望江南完成签到,获得积分10
6秒前
8秒前
完美世界的应助被复杂千亦采纳,获得10
8秒前
Mars发布了新的文献求助20
10秒前
xxx发布了新的文献求助10
10秒前
11秒前
11秒前
张丽妍发布了新的文献求助10
11秒前
传奇3的应助被魔幻寄真采纳,获得10
11秒前
shang发布了新的文献求助10
11秒前
13秒前
13秒前
冷酷代玉完成签到 ,获得积分10
13秒前
情怀的应助被YN采纳,获得10
13秒前
14秒前
酒精喵喵的应助被科研通管家采纳,获得10
14秒前
英勇的凤灵完成签到,获得积分10
14秒前
香蕉觅云的应助被科研通管家采纳,获得10
14秒前
赘婿的应助被科研通管家采纳,获得10
14秒前
华仔的应助被科研通管家采纳,获得20
15秒前
今后的应助被科研通管家采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
CODESSA Version 2.13 for Windows 2000
Agricultural Ecology (Liao Yuncheng & Lin Wenxiong) 1000
Rosenblum, Global Change Biology 800
Berberine regulates the TLR4 signaling pathway to suppress hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells 520
Organizational Behavior 510
Derham on the Law of Set Off (德勒姆论抵消法/第五版) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 有机化学 化学工程 内科学 物理 生物化学 复合材料 催化作用 细胞生物学 人工智能 心理学 无机化学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 7845162
求助须知:如何正确求助?哪些是违规求助? 9365530
关于积分的说明 20646285
捐赠科研通 7441213
什么是DOI,文献DOI怎么找? 3341319
关于科研通互助平台的介绍 2485212
邀请新用户注册赠送积分活动 2363729